- Home
- FTI vs PCVX Comparison
FTI vs PCVX Comparison
Compare FTI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- PCVX
- Stock Information
- Founded
- FTI 1884
- PCVX 2013
- Country
- FTI United States
- PCVX United States
- Employees
- FTI N/A
- PCVX N/A
- Industry
- FTI Metal Fabrications
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- FTI Industrials
- PCVX Health Care
- Exchange
- FTI Nasdaq
- PCVX Nasdaq
- Market Cap
- FTI 13.3B
- PCVX 11.5B
- IPO Year
- FTI N/A
- PCVX 2020
- Fundamental
- Price
- FTI $29.13
- PCVX $79.74
- Analyst Decision
- FTI Strong Buy
- PCVX Strong Buy
- Analyst Count
- FTI 13
- PCVX 8
- Target Price
- FTI $35.42
- PCVX $127.71
- AVG Volume (30 Days)
- FTI 3.1M
- PCVX 913.0K
- Earning Date
- FTI 02-27-2025
- PCVX 02-25-2025
- Dividend Yield
- FTI 0.69%
- PCVX N/A
- EPS Growth
- FTI N/A
- PCVX N/A
- EPS
- FTI 1.43
- PCVX N/A
- Revenue
- FTI $8,796,600,000.00
- PCVX N/A
- Revenue This Year
- FTI $16.28
- PCVX N/A
- Revenue Next Year
- FTI $9.74
- PCVX N/A
- P/E Ratio
- FTI $20.32
- PCVX N/A
- Revenue Growth
- FTI 17.82
- PCVX N/A
- 52 Week Low
- FTI $20.93
- PCVX $58.10
- 52 Week High
- FTI $33.45
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- FTI 37.36
- PCVX 36.96
- Support Level
- FTI $30.06
- PCVX $82.03
- Resistance Level
- FTI $31.25
- PCVX $84.10
- Average True Range (ATR)
- FTI 0.82
- PCVX 3.12
- MACD
- FTI -0.16
- PCVX -0.70
- Stochastic Oscillator
- FTI 13.08
- PCVX 1.88
About FTI TechnipFMC plc
TechnipFMC is the largest pure-play offshore oilfield service provider, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea engineering and construction services. The company also provides various surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of predecessor companies Technip and FMC Technologies.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.